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Abstract
Candida albicans is a leading human fungal pathogen that causes life-threatening systemic
infections. A key regulator of C. albicans stress response, drug resistance, morphogenesis,
and virulence is the molecular chaperone Hsp90. Targeting Hsp90 provides a powerful
strategy to treat fungal infections, however, the therapeutic utility of current inhibitors is com-
promised by toxicity due to inhibition of host Hsp90. To identify components of the Hsp90-
dependent circuitry governing virulence and drug resistance that are sufficiently divergent
for selective targeting in the pathogen, we pioneered chemical genomic profiling of the
Hsp90 genetic network in C. albicans. Here, we screen mutant collections covering ~10% of
the genome for hypersensitivity to Hsp90 inhibition in multiple environmental conditions.
We identify 158 HSP90 chemical genetic interactors, most of which are important for growth
only in specific environments. We discovered that the sterol C-22 desaturase gene ERG5
and the phosphatidylinositol-4-kinase (PI4K) gene STT4 are HSP90 genetic interactors
under multiple conditions, suggesting a function upstream of Hsp90. By systematic analysis
of the ergosterol biosynthetic cascade, we demonstrate that defects in ergosterol biosynthe-
sis induce cellular stress that overwhelms Hsp90’s functional capacity. By analysis of the
phosphatidylinositol pathway, we demonstrate that there is a genetic interaction between
the PI4K Stt4 and Hsp90. We also establish that Stt4 is required for normal actin polariza-
tion through regulation of Wal1, and suggest a model in which defects in actin remodeling
induces stress that creates a cellular demand for Hsp90 that exceeds its functional capacity.
Consistent with this model, actin inhibitors are synergistic with Hsp90 inhibitors. We high-
light new connections between Hsp90 and virulence traits, demonstrating that Erg5 and
Stt4 enable activation of macrophage pyroptosis. This work uncovers novel circuitry regulat-
ing Hsp90 functional capacity and new effectors governing drug resistance, morphogenesis
and virulence, revealing new targets for antifungal drug development.
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Author Summary
Hsp90 is an essential and conserved molecular chaperone that is required for the folding
and function of a wide range of client proteins, especially those involved in signaling and
stress responses. In the human fungal pathogen Candida albicans, Hsp90 governs drug
resistance, morphogenesis, and virulence. In our previous analysis, we developed a chemi-
cal genomic approach to map the HSP90 chemical genetic network in C. albicans, an
organism for which classical genetic approaches are hampered by the lack of a complete
sexual cycle. Here, we confirm the environmental contingency of the Hsp90 genetic net-
work in C. albicans, identify novel genetic interactions, and demonstrate new circuitry that
regulates Hsp90 functional capacity in the cell. In the context of treatment of infectious
disease, the challenge in avoiding host toxicity and achieving specificity lies in either the
development of pathogen-selective Hsp90 inhibitors or identifying pathogen-specific com-
ponents of the circuitry through which Hsp90 governs virulence. This work provides
insight into such circuitry in the leading fungal pathogen of humans.
Introduction
Hsp90 is an ATP-dependent molecular chaperone that stabilizes components of diverse signal
transduction cascades, especially those involved in adaptation to stress [1]. Hsp90 function is
modulated by co-chaperones, which are thought to mediate recognition of client proteins,
many of which cycle dynamically through complexes with Hsp90 until their activation [2].
Hsp90 can be regulated in response to environmental stress at the transcriptional level, such as
with the induction observed in response to high temperature via the transcription factor Hsf1.
Hsp90 can also be regulated by a dynamic code of post-translational modifications, including
phosphorylation, acetylation, and nitrosylation [2]. Despite the complex cellular control of
Hsp90 function, environmental stress can induce global protein misfolding that overwhelms
the chaperone’s functional capacity [3].
As a consequence of Hsp90’s role as a central hub of protein homeostasis and regulatory cir-
cuitry, it provides an Achilles’Heel that can be targeted to cripple diverse organisms, including
fungal pathogens. Fungi are a leading cause of human mortality worldwide. These eukaryotic
pathogens infect 1.7 billion people and kill more than 1.5 million people annually [4]. Candida
albicans is a leading fungal pathogen of humans, accounting for 9–12% of all hospital-acquired
bloodstream infections, with an attributable mortality rate of 38%, despite significant advances
in diagnosis and the increased use of antifungal therapies [5]. In C. albicans, Hsp90 plays key
roles in the pathogenesis-relevant phenotypes of morphogenesis, antifungal drug resistance,
and response to host stresses [6–9]. Hsp90 inhibition abrogates resistance to the azoles and the
echinocandins, which are clinically important antifungals that target the fungal cell membrane
and the cell wall, respectively [8,10]. Genetic depletion or pharmacological inhibition of Hsp90
also induces a morphological transition from yeast to filamentous growth; the capacity to tran-
sition between these states is a key virulence trait [11,12].
Hsp90 regulates fungal drug resistance and morphogenesis by stabilizing key regulators of
cellular signaling. Hypothesis-driven approaches have identified the protein phosphatase calci-
neurin and the terminal mitogen-activated protein kinase (MAPK) of the protein kinase C
(PKC) cell wall integrity pathway, Mkc1, as Hsp90 client proteins that are crucial for drug
resistance [10,13]. Small scale screens covering ~3% of the genome have revealed that Hsp90
regulates morphogenesis through Ras1-PKA signaling [9], and through a pathway that
includes the cyclin Pcl1, cyclin-dependent kinase Pho85, and transcription factor Hms1 [14].
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We also identified the cyclin-dependent kinase Cdc28 [15], and three transcription factors,
Cph2, Hap5, and Stp2 [9], as important effectors through which Hsp90 controls morphogene-
sis. The pleiotropic effect of Hsp90 on cellular circuitry demands a systematic approach to
explore Hsp90 genetic interaction networks to identify effectors through which it governs drug
resistance and morphogenesis.
We previously pioneered a chemical genomic approach to map the genetic interactors of
Hsp90 in C. albicans, an organism for which classical genetic approaches are hampered by the
lack of a complete sexual cycle [16]. Chemical inhibitors provide a powerful approach to detect
genetic interactions when a mutant allele of one gene causes an unexpected phenotype in the
presence of a chemical. Chemical genomics has revealed gene function and genetic networks in
the model yeast Saccharomyces cerevisiae [17], and provides a powerful approach to define
HSP90 interactors [18,19]. Mapping HSP90 chemical genetic interactions is facilitated by the
availability of potent and highly specific inhibitors of Hsp90 function, including the natural
product geldanamycin, which binds in the unusual nucleotide binding pocket of Hsp90, block-
ing ATPase activity and leading to the degradation of client proteins [20]. In our original
study, we screened a C. albicans transposon mutant library covering ~10% of the genome for
hypersensitivity to geldanamycin under standard growth conditions and five stress conditions,
in order to identify environmentally contingent interactions [16]. We identified 226HSP90
chemical genetic interactors, most of which were important for growth only under specific con-
ditions. A small number of HSP90 interactors were identified in multiple stress conditions in
addition to under standard conditions; these pleiotropic effects suggested that they function
upstream ofHSP90. Consistent with this model, interactors identified in the majority of condi-
tions included the transcription factor gene AHR1, which regulates HSP90 expression, and the
genes encoding regulatory subunits of protein kinase CK2, which control Hsp90 phosphoryla-
tion and function [16]. This work illustrated the power of chemical genomics to map functional
connections and genetic networks in C. albicans.
Here, we build upon our previous HSP90 genetic interaction network by screening two
additional mutant libraries covering 772 genes for hypersensitivity to geldanamycin, expanding
our coverage to ~20% of the genome. From this, we identify 11 strongHSP90 chemical genetic
interactors under basal conditions, and an additional 147 HSP90 chemical genetic interactors
that are required for growth under stress. We focused on the sterol C-22 desaturase gene ERG5
and the phosphatidylinositol-4-kinase (PI4K) gene STT4, and demonstrate that they regulate
the functional capacity of Hsp90, providing new avenues for antifungal drug development.
Results
Chemical genetic screening for Hsp90 genetic interactors
We extended our previous analysis of theHSP90 genetic interaction network in C. albicans, uti-
lizing the same chemical genomic approach to screen two additional mutant libraries that
cover 772 genes, including 566 ORFs distinct from the previous screen [11,21]. An advantage
of these libraries over that used in our previous analysis is that these are composed of precise
homozygous deletion mutants rather than transposon insertion mutants. Each strain was
screened for growth under standard host-relevant conditions (RPMI, 37°C) in the presence
and absence of a low concentration of the pharmacological Hsp90 inhibitor geldanamycin
(3 μM) that does not affect growth of the wild-type strain. This revealed 11 genes that are
strong genetic interactors of Hsp90 (Fig 1A), as the corresponding mutants had at least 50%
reduction in growth in response to this low dose of Hsp90 inhibition. Of these, mutants lacking
the sterol C-22 desaturase gene ERG5 and the phosphatidylinositol-4-kinase (PI4K) gene STT4
demonstrated the greatest sensitivity to Hsp90 inhibition. These genetic interactions were
C. albicansHsp90 Genetic Interactors
PLOS Genetics | DOI:10.1371/journal.pgen.1006142 June 24, 2016 3 / 21
Fig 1. Mapping theC. albicansHsp90 genetic interaction network. (A) Chemical genomic screening revealed 11 mutants that are
hypersensitive to Hsp90 inhibition. Strains were screened at 3 μM geldanamycin in RPMI at 37°C, and percent growth is normalized to the no
drug condition. * indicates p <0.05 compared to the wild-type strain using t-tests. (B) TheHSP90 genetic interaction network is
environmentally contingent. The network is composed of 158 genetic interactors identified in five different growth conditions (grey boxes).
EachHSP90 genetic interactor is indicated by a box, with edges connecting it to the environmental conditions in which it interacts with HSP90.
The color of the box reflects the number of conditions in which the mutant demonstrates hypersensitivity to Hsp90 inhibition, with the majority
C. albicansHsp90 Genetic Interactors
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confirmed using Gene Replacement And Conditional Expression (GRACE) strains [22,23],
whose target gene expression is repressible using the tetracycline analog doxycycline (S1 Fig).
This confirms that the sensitivity of the stt4Δ/Δ and erg5Δ/Δmutants to geldanamycin is due to
the specific genetic perturbation and not to spurious mutations.
Our previous analysis of Hsp90 genetic interactors suggested that many interactions are
dependent upon additional stress to the cell, including ones that mimic stresses occurring in
the human host. Therefore, we screened the mutant libraries [11,21] for hypersensitivity to gel-
danamycin under the general stresses of high temperature (41°C, human febrile temperatures),
osmotic stress (NaCl), and unfolded protein stress (tunicamycin). We also used treatment with
low concentrations of the commonly used antifungal drugs caspofungin, which targets the cell
wall, and fluconazole, which targets ergosterol biosynthesis and causes cell membrane stress
and toxic sterol accumulation. For these screens, we calculated whether there was a genetic
interaction upon stress using the Product Multiplicative Model [24,25]. We used a conservative
cut-off that defined a chemical genetic interaction if the observed fitness under the combined
stress condition was less than half of the expected fitness determined from the singular treat-
ment of stress or geldanamycin alone in at least two independent mutants for each gene
FitnessðstressþgeldanamycinÞ <
FitnessðstressÞFitnessðgeldanamycinÞ
2
. This was a more stringent cutoff than our previ-
ous screen, minimizing false positive interactions; however, it resulted in exclusion of some
previously identiﬁed genetic interactors. For example, we observed that ORF19.1219 and
ORF19.1496 are genetic interactors withHSP90 in response to caspofungin, similar to the pre-
vious screen, but they only had a 40% greater than expected reduction in ﬁtness and were thus
excluded from our more stringent set of genetic interactors. For the 11 mutants that were
found to be hypersensitive to 3 μM geldanamycin alone, we calculated genetic interactions
upon stress using a lower concentration of geldanamycin that had minimal impact on growth
(Fig 1A and 1B, thick outline). This allows us to determine whether these genetic interactions
are also observed under other stress conditions, indicating that these genes have pleiotropic
effects that could suggest a role upstream of Hsp90.
Together, these screens identified 158 chemical genetic interactors of Hsp90 (S1 Table). The
majority of the genetic interactions were only observed under a single growth condition, with
caspofungin yielding the most genetic interactors. Six genes were HSP90 genetic interactors
under three stress conditions, implicating them as high-connectivity interactors. Interestingly,
the uncharacterized gene ORF19.194, the septin gene CDC10, and the transcription factor gene
ZCF2, which did not confer sensitivity to geldanamycin under standard conditions, were high-
connectivity interactors under stress. Together, this highlights the environmental contingency
of the Hsp90 chemical genetic interactions. We also examined the role of all of these genetic
interactors in morphogenesis and drug resistance. As with Hsp90, many of these genetic inter-
actors were found to be important for filamentation or susceptibility to antifungal drugs (S2
Fig), demonstrating thatHSP90 genetic interactors regulate morphogenesis and cellular
responses to antifungal drugs.
For mutants that were hypersensitive to geldanamycin (Fig 1A), we observed varying num-
bers of genetic interactions under the stress conditions (Fig 1B). There are three models for
why an Hsp90 genetic interactor under basal conditions would not also be a genetic interactor
under stress conditions. First, false negatives can result if the mutant has a low fitness under
the individual stress conditions, causing the fitness under the combined stresses to be below
the limit of detection. Second, activation of specific stress responses may compensate for the
of interactions only occurring under a single environmental condition. FLU = fluconazole, C = caspofungin, T = tunicamycin. Thick black
outline = screened at 1 μM geldanamycin except for stt4Δ/Δ which was screened at 0.375 μM geldanamycin.
doi:10.1371/journal.pgen.1006142.g001
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loss of a gene. Third, distinct sets of Hsp90-dependent client proteins are crucial for cellular
viability in different environmental conditions [19]. Screening for Hsp90 genetic interactions
under multiple stress conditions therefore produces a comprehensive map of general and con-
dition-specific Hsp90 genetic interactors.
STT4, ERG5, and SNT1 are bona fide Hsp90 genetic interactors
Based on our analysis, we identified STT4, ERG5, and the Set3C lysine deacetylase SNT1 as the
strongest chemical genetic interactors of HSP90 under standard growth conditions (Fig 1A)
that are also chemical genetic interactors under stress conditions, implicating them as high
connectivity interactors in our network (Fig 1B). To validate the genetic interactions between
HSP90 and STT4, ERG5, and SNT1, we created double mutant strains where the only allele of
HSP90 was under the control of the tetO tetracycline-repressible promoter in the stt4Δ/Δ,
erg5Δ/Δ, and snt1Δ/Δmutant backgrounds. Construction of hsp90Δ/Δ deletion mutants is pre-
cluded by the fact that Hsp90 is essential in all eukaryotes tested [26]. We measured fitness of
all of the strains in the presence of the tetracycline analog doxycycline to repress HSP90 expres-
sion. Using the Product Multiplicative Model of genetic interactions [24,25], we determined
that the fitness defects of the double mutant strains were more severe than the product of each
single mutant fitness defect (Fig 2), confirming the genetic interactions. This genetic validation
rules out the possibility that hypersensitivity of the stt4Δ/Δ, snt1Δ/Δ, and erg5Δ/Δmutants to
geldanamycin is due to alterations in geldanamycin accumulation in the cell or off-target
effects of the drug, confirming that STT4, ERG5 and SNT1 are bona fide genetic interactors of
HSP90.
Fig 2. ERG5, STT4, and SNT1 are genetic interactors ofHSP90. The fitness defect of the tetO-HSP90/
hsp90Δ and stt4Δ/Δ, erg5Δ/Δ, or snt1Δ/Δ double mutant strains is greater than the product of the fitness
defect of each individual mutant. The dotted line indicates the expected double mutant fitness defect. In the
tetO-HSP90/hsp90Δ strains,HSP90 depletion is achieved by transcriptional repression with 0.05 μg/mL
doxycycline (DOX).
doi:10.1371/journal.pgen.1006142.g002
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Loss of STT4 or ERG5 alters Hsp90 functional capacity
The genetic interaction network (Fig 1) can be separated into two types of interactions—low
connectivity, where the mutant is only hypersensitive to Hsp90 inhibition under one environ-
mental condition, and high connectivity, where the mutant is sensitive to Hsp90 inhibition
under multiple conditions. In our previous work, we demonstrated that high connectivity
interactors are likely to function upstream of Hsp90, and influence Hsp90 expression or func-
tion [16]. Based on this logic, we hypothesized that Stt4, Erg5, and Snt1 would function
upstream of Hsp90, due to their genetic interactions with Hsp90 in both basal and multiple
stress conditions. To determine whether Stt4, Erg5, and Snt1 affect Hsp90 at the protein level,
we measured Hsp90 protein levels in the mutant strains by Western blotting (Fig 3A). Hsp90
levels were not decreased the stt4Δ/Δ, erg5Δ/Δ, and snt1Δ/Δmutants, and were in fact slightly
increased, suggesting that they must influence Hsp90 via another mechanism.
To determine whether these genes affect Hsp90 function, we first monitored phosphoryla-
tion of the Hsp90 client protein Hog1 in the wild-type, stt4Δ/Δ, erg5Δ/Δ, and snt1Δ/Δ strains.
Hog1 is a terminal mitogen activated protein kinase (MAPK) involved in adaptation to oxida-
tive stress. Hog1 requires Hsp90 for stabilization and activation [16]; there is a decrease in the
levels of total and phosphorylated Hog1 when Hsp90 function is compromised. We observed
reduced levels of phosphorylated Hog1 in response to peroxide stress in the stt4Δ/Δ and erg5Δ/
Δmutant strains compared to the wild type (Fig 3B), consistent with a decrease in Hsp90 chap-
erone function. However, Hog1 phosphorylation was not decreased in the snt1Δ/Δ strain.
Fig 3. Stt4 and Erg5 modulate the cellular requirements for Hsp90. (A) Hsp90 levels are not decreased in the stt4Δ/Δ,
erg5Δ/Δ, or snt1Δ/Δmutant strains compared with the wild type. Hsp90 levels were normalized to the tubulin loading control
and the relative levels were compared with the wild-type strain. (B) Hog1 activation is decreased in the mutant strains.
Strains were treated with or without 10 mM hydrogen peroxide to induce Hog1 phosphorylation. Protein levels were
normalized to the H3 loading control and the levels of total Hog1 and pHog1 were determined relative to the wild-type strain
under the same conditions. (C) Low doses of the Hsp90 inhibitor geldanamycin are sufficient to induce filamentation in the
stt4Δ/Δ and erg5Δ/Δmutant strains. Strains were incubated for 6 hours in YPD in the presence of 2.5 μM geldanamycin
before imaging. Scale bar is 10 microns.
doi:10.1371/journal.pgen.1006142.g003
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As a second reporter for Hsp90 function, we examined the capacity of Hsp90 to repress fila-
mentation via the Ras signaling cascade [9]. Inhibition of Hsp90 using 10 μM geldanamycin is
sufficient to relieve this repression and induce filamentous growth [9]. We reasoned that if
Hsp90 function were compromised in the mutant strains, a lower concentration of Hsp90
inhibitor would be sufficient to induce filamentation in the mutants compared to the wild-type
strain. Consistent with this hypothesis, we found that 2.5 μM geldanamycin induced robust
filamentation in the erg5Δ/Δ and stt4Δ/Δmutants but not in the wild-type strain (Fig 3C). This
demonstrates a divergence in the requirements for a phosphoinositide bis-phosphate (PIP2)
gradient during serum and Hsp90-compromise induced filaments, as C. albicans stt4Δ/Δ
mutants are defective in filamentation in response to serum [27]. Additionally, the snt1Δ/Δ
mutant behaved as the wild type, suggesting that Snt1 may either act in a parallel pathway to
Hsp90, or have specific functions in regulating Hsp90 that are not captured by our reporter
assays. Together, these results are consistent with a model in which Erg5 and Stt4 regulate
Hsp90 function or the cellular demand for Hsp90.
Accumulation of sterol intermediates changes the cellular demand for
Hsp90
Consistent with our findings that ERG5 is anHSP90 genetic interactor, previous analyses of C.
albicans strains resistant to the membrane disrupting antifungal drug amphotericin B demon-
strated that deletion of the ergosterol biosynthesis genes ERG6, ERG2, or combined deletion of
both ERG3 and ERG11 caused hypersensitivity to geldanamycin. Deletion of these ergosterol
genes was found to increase basal stress levels, suggesting that the cellular reservoirs of Hsp90
were depleted [28]. We examined whether this was specific to strains that are resistant to
amphotericin B, or whether perturbation of the entire ergosterol biosynthesis pathway would
confer a similar hypersensitivity to Hsp90 inhibition. To do so, we tested 18 tetracycline-
repressible conditional expression strains for ergosterol biosynthesis genes from the GRACE
collection [22,23] for hypersensitivity to Hsp90 inhibition in the presence of doxycycline to
repress target gene expression. We observed that the ERG24, ERG2, ERG3, ERG5 and ERG6
conditional expression strains were all hypersensitive to geldanamycin (Fig 4A). Interestingly,
transcriptional repression of ERG10, ERG20, ERG7, and ERG26 had little effect on geldanamy-
cin sensitivity. However, many of the other ergosterol biosynthesis genes are essential, preclud-
ing their analysis for geldanamycin hypersensitivity [23]. Therefore, we used small molecule
inhibitors of the ergosterol biosynthetic cascade to further explore the relationship between
ergosterol biosynthesis and Hsp90. As seen previously, synergy was observed between geldana-
mycin and the Erg11 inhibitor fluconazole (FIC90 = 0.09) (Fig 4B) [7,8]. Synergy with geldana-
mycin was also observed between the allylamine terbinafine (FIC90 = 0.25), which targets Erg1,
and the morpholine fenpropimorph (FIC90 = 0.016), which targets Erg24 and Erg2 (Fig 4B). In
contrast, amphotericin B, which binds ergosterol and removes it from the membrane [29,30],
does not show synergy with geldanamycin (FIC90 = 0.75) (Fig 4B).
Together, this suggests that it is not the lack of ergosterol per se that confers hypersensitivity
to Hsp90 inhibition, but rather incorporation of specific sterol intermediates into the mem-
brane. These altered sterols could cause altered membrane fluidity, which is important for tem-
perature sensing, stress responses, and activation of the heat shock response [31]. To test this
hypothesis, we supplemented the erg5Δ/Δmutant strain with 50 μM ergosterol under condi-
tions that allow for sterol uptake [32]. We also examined this relationship in the erg3Δ/Δ
mutant strain, which does not produce the canonical toxic sterol intermediate, 14-α-methyl-
3,6-diol [33]. We observed no rescue in geldanamycin hypersensitivity for either mutant strain
upon addition of ergosterol (Fig 4C), suggesting that incorporation of specific sterol
C. albicansHsp90 Genetic Interactors
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intermediates into the cell membranes is sufficient to induce cellular stress and overwhelm the
functional capacity of Hsp90.
Perturbation of STT4 alters actin localization throughWal1, changing
cellular demand for Hsp90
C. albicans Stt4 is a type III phosphatidylinositol-4-kinase (PI4K); previous work in mamma-
lian cells demonstrated that the type IIβ PI4K protein is stabilized by Hsp90 [34]. Therefore,
we examined the stability of CaStt4 upon Hsp90 depletion. To do so, we engineered an N-ter-
minally FLAG-tagged STT4 allele under the ACT1 promoter in the tetO-HSP90/hsp90Δ back-
ground, and monitored FLAG-Stt4 protein levels upon transcriptional repression ofHSP90
with doxycycline (Fig 5A). There was no reduction in FLAG-Stt4 levels upon Hsp90 depletion,
indicating that that unlike in mammalian cells, Stt4 is not a client protein of Hsp90 in C.
albicans.
In S. cerevisiae, Stt4 function is controlled by two proteins, Ypp1 and Efr3, which help local-
ize Stt4 to the membrane [35]. To investigate the function of the entire PI4K complex in C.
albicans, we examined the putative ORFs encoding Ypp1 (ORF19.4163, 26% protein identity
with S. cerevisiae) and Efr3 (ORF19.4798, 30% identity with S. cerevisiae). To determine if these
proteins share a common function with Stt4 in C. albicans, we created the ypp1Δ/Δ and efr3Δ/Δ
deletion strains. Similar to the stt4Δ/Δ deletion strain, the ypp1Δ/Δ and efr3Δ/Δmutant strains
were hypersensitive to geldanamycin (Fig 5B), demonstrating that Ypp1 and Efr3 are also
genetic interactors of Hsp90. We then examined whether alterations in phosphatidylinositol
signaling in general, or the production of phosphatidylinositol 4-phosphate (PI4P) specifically
by Stt4 was important for geldanamycin sensitivity by testing four available phosphatidylinosi-
tol kinase and phosphatase mutants. However, the stt4Δ/Δmutant was the only mutant with
dramatic hypersensitivity to Hsp90 inhibition under basal conditions, suggesting that the
genetic interaction between Stt4 and Hsp90 is specific (S2 Table).
We then took an unbiased approach to identify downstream effectors of Stt4 by examining
C. albicans proteins with pleckstrin homology (PH) or pleckstrin homology-like domains (S2
Table); these domains bind phosphatidylinositols and help localize proteins to specific mem-
branes. We also searched for proteins that are computationally predicted to bind to phosphati-
dylinositol-4-phosphate. We identified 42 genes encoding such proteins in the C. albicans
genome, and examined 30 available mutants corresponding to these genes for geldanamycin
sensitivity. Only the osh3Δ/Δ and tetO-WAL1/wal1Δmutant strains were hypersensitive to
Hsp90 inhibition, suggesting that modulation or perturbation of the localization of these pro-
teins mediate the sensitivity of the stt4Δ/Δmutant to geldanamycin (Fig 5C and S2 Table).
Wal1 is the homolog of the S. cerevisiae Las17 actin nucleation promotion factor, and is
required for actin remodeling in C. albicans [36]. Although the PI4K complex is known to reg-
ulate actin polarization in S. cerevisiae [37], ScLas17 does not contain a PH domain. We used
Fig 4. Perturbation of ergosterol biosynthesis causes hypersensitivity to Hsp90 inhibitors. (A) Mutants
of ergosterol biosynthesis genes are hypersensitive to geldanamycin. Minimum inhibitory concentration
(MIC) assays were performed in RPMI medium at 37°C for 48 hours and optical densities at 600 nm were
averaged for two biological replicates with two technical replicates each. Percent growth is normalized to the
no drug condition. To deplete target gene expression, the strains were incubated in 0.05 μg/mL doxycycline
(DOX). (B) Chemical inhibition of the ergosterol biosynthetic pathway using fluconazole, fenpropimorph, or
terbinafine leads to synergy with the Hsp90 inhibitor geldanamycin. Synergy is not observed with
amphotericin B, which binds to ergosterol in the membrane. Dose response matrixes were performed with the
wild-type strain in YPD and incubated for 24 hours. (C) Hypersensitivity to geldanamycin is not rescued by
addition of ergosterol. Strains were incubated with either 50 μM ergosterol or with the vehicle (ethanol) in
RPMI at 37°C for 48 hours.
doi:10.1371/journal.pgen.1006142.g004
C. albicansHsp90 Genetic Interactors
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rhodamine-phalloidin staining of F-actin in the wild type and the stt4Δ/Δmutant strain, and
observed a defect in polarized actin at the tip of elongating cells in the stt4Δ/Δmutant (Fig 5D).
This was confirmed with the doxycycline-repressible STT4mutant, demonstrating that the
actin polarization defect can be attributed to loss of Stt4 (S3 Fig). We observed a similar effect,
though more drastic, upon doxycycline-mediated transcriptional repression ofWAL1 in the
tetO-WAL1/wal1Δ depletion strain (Fig 5D). Together, this suggests that Stt4 is required for
producing the PI4P used to localize Wal1, which is a requirement for normal actin remodeling
and stress tolerance. This led us to hypothesize that defects in actin organization cause
increased cellular demand for Hsp90, thus sensitizing the cell to Hsp90 inhibition. To test this,
we examined the interaction between cytochalasin A, which prevents actin polymerization,
and geldanamycin (Fig 5E). We observed synergy (FIC90 = 0.375) in the wild-type strain but
not in the stt4Δ/Δmutant (FIC90 = 0.750), suggesting that the primary cause of geldanamycin
hypersensitivity in the stt4Δ/Δmutant is due to perturbation of actin. Interestingly, many other
genes that regulate cytoskeletal dynamics in C. albicans were not genetic interactors with
Hsp90 (S2 Table), suggesting that there is specificity in the interaction between Stt4, Wal1, and
Hsp90.
The impact of Erg5, Snt1, and Stt4 on virulence
Given that Hsp90 has a profound impact on virulence traits, such as response to stress and
morphogenetic transitions, we next assessed the impact of the three Hsp90 genetic interactors,
ERG5, SNT1, and STT4, on virulence; our hypothesis was that defects in Hsp90 function would
result in decreased virulence. To test this hypothesis, we utilized a macrophage model of viru-
lence, where we assessed the capacity of the mutant strains to induce pyroptosis and kill macro-
phages [23]. We used bone-marrow-derived macrophages that have been stably transformed
with an mCherry-labelled ASC protein. This protein oligomerizes upon NLRP3-dependent
pyroptosis [38], allowing us to precisely assess the ability of the C. albicans cells to induce mac-
rophage pyroptosis. Notably, the stt4Δ/Δmutant demonstrated slightly reduced filamentation
within host cells (Fig 6A), although the defect in filamentation in macrophages was not as
severe as in serum [27]. Importantly, all three mutant strains were significantly attenuated for
macrophage lysis compared with the wild-type strain (p< 0.05 with Bonferroni corrections,
Fig 6B), suggesting that these Hsp90 genetic interactors have a role in virulence. We validated
our findings with the tetO-ERG5/erg5Δ and tetO-STT4/stt4Δ strains upon doxycycline treat-
ment (S4 Fig). This highlights the utility of Hsp90 genetic interactors as targets for antifungal
drug development.
Discussion
Our expanded map of the Hsp90 genetic interaction network in C. albicans reveals key pertur-
bations in the genetic architecture of the cell that induce severe cellular stress, and further iden-
tifies novel effectors governing drug resistance, morphogenesis, and virulence. Our screen of
772 homozygous deletion mutants for hypersensitivity to geldanamycin delineated a network
Fig 5. Stt4 genetic interactions with Hsp90 are mediated throughWal1 regulation of actin. (A) Stt4 is not a client protein of Hsp90. Protein levels
of N-terminally FLAG-tagged Stt4 were monitored in the tetO-HSP90/hsp90Δ background. Strains were incubated with or without 0.5 μg/mL DOX for
24 hours to deplete Hsp90 before protein extraction. Hsp90 levels are detected using an antibody againstC. albicansHsp90. Representative blots
are shown here, with tubulin as a loading control. (B) Ypp1 and Efr3 are two additional members of the Stt4 complex that influence tolerance to
geldanamycin. MIC assays were performed as described in Fig 4. (C) The PH-domain proteins Osh3 andWal1 are genetic interactors with Hsp90.
MIC assays were performed as described in Fig 4. (D) Stt4 andWal1 are required for normal actin localization in the cell. Strains were sub-cultured in
RPMI at 37°C for 6 hours before fixation and staining with rhodamine-phalloidin for F-actin. (E) Actin inhibitors are synergistic with Hsp90 inhibitors.
Dose response matrixes were performed in RPMI at 37°C and incubated for 38 hours.
doi:10.1371/journal.pgen.1006142.g005
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of 158 HSP90 chemical genetic interactors, most of which were specific for a single environ-
mental condition (Fig 1). The low connectivity interactors are likely to enable growth in
response to specific conditions, as with the PKC pathway MAP kinaseMKC1 [13,39] or the
Hog1 MAPKKK SSK2, which are genetic interactors with NaCl treatment. The more pleiotro-
pic high connectivity interactors that were identified in many conditions are likely to either
operate upstream of HSP90 [16], or to modulate the cellular demand for the chaperone
machinery. Our cumulative screens to date now cover ~20% of the genome and have identified
352 distinctHSP90 genetic interactors. This work has established important principles through
which network connectivity can reveal pathway order and functional relationships in the cell.
Surprisingly, some of the HSP90 genetic interactors identified in basal conditions were clas-
sified as low connectivity interactors, as their genetic interaction was not maintained under
stress conditions (Fig 1). This is likely due to condition-specific functions of Hsp90 or the gene
of interest. For example, previous S. cerevisiae screens have found divergence in Hsp90 chemi-
cal genetic interactors under basal and stress conditions due to condition-specific functions of
Hsp90 [19]. Under basal conditions, they found that Hsp90 function is important for the secre-
tory pathway, protein transport, as well as forming and stabilizing oligomeric complexes; in
stress conditions, Hsp90 is essential for control of cell cycle, meiosis, and cytokinesis [19].
Genetic interactions can also differ between environmental conditions based on condition-spe-
cific expression or activation of compensatory pathways.
Our network provides a glimpse of the circuitry that modulates the functional capacity of
Hsp90. With STT4, ERG5, and SNT1 identified as HSP90 chemical genetic and bona fide
genetic interactors under both basal and stress conditions (Figs 1 and 2), this suggests that they
could operate upstream ofHSP90 or that they modulate the cellular requirements for the
Fig 6. Stt4, Erg5, and Snt1 are required forC. albicans virulence. (A) Representative images of infections. ASC-mCherry
macrophages were infected with the indicated strains and monitored for pyroptosis by foci of fluorescence Scale bar is 50
microns (B) Average percent pyroptosis, * indicates p < 0.05, error bars indicate standard deviation. At least 700 infected cells
were counted per strain.
doi:10.1371/journal.pgen.1006142.g006
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chaperone machinery. The biochemical functions of phosphatidylinositol signaling and ergos-
terol biosynthesis are unlikely to directly impinge on regulation of Hsp90 function, but these
are processes intimately coupled with modulating cellular integrity, signaling, and stress. Con-
sistent with the model that perturbation of these pathways induces a state of cellular stress that
overwhelms Hsp90’s functional capacity, we found that despite a modest increase in Hsp90 lev-
els in the erg5Δ/Δ and stt4Δ/Δmutants, Hsp90 function in stabilizing two distinct signaling cas-
cades was compromised (Fig 3). In the snt1Δ/Δmutant strain, however, we did not observe
alterations in Hsp90 function, suggesting that Snt1 either acts in a parallel pathway with
Hsp90, or affects a subset of Hsp90 functions. Our work, and that of others has demonstrated
that Hsp90 deacetylation is a key component of drug resistance [40,41], suggesting that Snt1,
and the entire Set3C lysine deacetylase complex, may have specific roles in governing Hsp90
function in drug resistance. Overall, targeting core cellular homeostasis pathways provides a
powerful strategy to induce cellular stress that can be exploited to cripple fungal pathogens.
One core cellular process is the incorporation of ergosterol in the membrane. Impairing
ergosterol biosynthesis can lead to accumulation of sterol intermediates in the membrane,
which has profound impacts on membrane fluidity, membrane integrity and the functions of
diverse signaling cascades [26,31,42]. We found that perturbation of ergosterol biosynthesis at
multiple stages causes hypersensitivity to Hsp90 inhibition, consistent with previous findings
that ERG1, ERG2, ERG5, and ERG6 are HSP90 genetic interactors in S. cerevisiae [18,19]. This
link between Hsp90 and ergosterol biosynthesis was further corroborated by synergy between
an Hsp90 inhibitor and antifungals that target the ergosterol biosynthesis pathway (Fig 4).
Indeed, mutations in the ergosterol biosynthesis pathway that confer resistance to amphoteri-
cin B create severe cellular stress that renders the fungus vulnerable to attack by host defenses
[28]. By exploring the details of the genetic interactions between Hsp90 and the ergosterol bio-
synthetic cascade, we demonstrate that the incorporation of altered sterols into the membrane
is sufficient to induce cellular stress, which overwhelms Hsp90’s functional capacity.
Another core process regulating the cellular demand for Hsp90 and the tolerance of antifun-
gal drugs is phosphatidylinositol-4-phosphate synthesis by Stt4. We demonstrate that the
phosphatidylinositol-4-kinase (PI4K) gene STT4 is a strong Hsp90 genetic interactor (Fig 5), as
are two uncharacterized orthologs of additional components of the PI4K complex in S. cerevi-
siae, EFR3 and YPP1 [35]. In our previous study, we identified the VPS34 and VPS15 PI3
kinases as Hsp90 genetic interactors, but only under high temperature and high salt stress [16].
Based on analysis of downstream effectors of Stt4, we propose a model in which PI4P created
by Stt4 is required for localization of Wal1 and thus normal actin remodeling during growth.
In the absence of Stt4, actin remodeling is altered, resulting in stress that creates a cellular
demand for Hsp90 that exceeds its functional capacity. One mechanism for this stress could be
the altered regulation of glycolysis, leading to metabolic stress. In mammalian cells, PI3K sig-
naling is required for actin remodeling, release of aldolase A, and enhanced glycolytic flux [43].
However, many of the other factors involved in this process, such as the GTPases that work
with Rac1, were not identified as genetic interactors with HSP90 in our study (S2 Table).
Targeting Hsp90 and key components of the chaperone genetic network provides a power-
ful strategy to treat life threatening infectious disease caused by diverse eukaryotic pathogens.
Pharmacological inhibition of Hsp90 itself is facilitated by the phenomenal progress made in
the development of potent compounds that selectively inhibit this chaperone, driven in large
part by the desire to target Hsp90’s key role in stabilizing multiple oncogenic proteins and
enabling malignant transformation [44,45]. These molecules can transform antifungals from
ineffective to highly efficacious in mammalian models of fungal biofilm infections, where the
infection and drug delivery are localized [46]. Beyond Hsp90, other chaperone network com-
ponents have emerged as promising targets for therapeutic intervention that are more
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divergent between pathogen and host, as is the case with Stt4 and Snt1, which have only 45%
and 30% sequence identity to their closest human ortholog. Recent work in antimalarials iden-
tified a Plasmodium type III PI4 kinase as a target of imidazopyrazines [47], which could have
broad relevance for fungal pathogens given the profound impact of perturbation of Stt4 func-
tion on cellular stress and virulence. Moreover, the alteration in Hsp90 functional capacity in
the stt4Δ/Δ and erg5Δ/Δmutants may minimize the potential for the evolution of antifungal
drug resistance [8]. Fitness constraints associated with the evolution of resistance to Hsp90
inhibitors in combination with antifungals [48], suggests promising strategies for the rational
design of antifungal combinations that evade drug resistance.
Methods and Materials
Chemical genomic screening
The C. albicans homozygous deletion libraries were obtained from the Fungal Genetics Stock
Center and maintained in cryo-culture at -80°C. Individual strains were inoculated into
96-well plates in 100 μL RPMI-1640 pH 7 (10.4 g/l RPMI-1640, 3.5% MOPS, 2% glucose), sup-
plemented with 5 mg/L histidine. The plates were sealed with Adhesive Plate Seals (Thermo
Scientific) and incubated overnight at 37°C while shaking at 200 rpm. Cells were then diluted
twice. First, using the VP408 96 Pin Multi-Blot Replicator (VP Scientific), 0.5 μl of Candida
culture was inoculated in 200 μl of 1X phosphate buffered saline (PBS) (1:400 dilution). This
mixture was then diluted a further ten-fold into 200 μl RPMI-1640, RPMI with 3 μM geldana-
mycin (LC laboratories, G-4500), RPMI with stressor (S3 Table), or RPMI with both 3 μM gel-
danamycin and stressor in flat bottom 96-well plates. For the 11 mutants with strong
hypersensitivity to Hsp90 inhibition, screening was repeated at the sub-inhibitory concentra-
tions of 1 μM geldanamycin for all mutants except stt4Δ/Δ, which required 0.375 μM. Plates
were incubated at the indicated conditions (S3 Table) and growth was measured by optical
densities (ODs) at λ = 600 nm.
Strain construction
All strains were maintained in cryo-culture at -80°C in 25% glycerol and passaged in YPD. All
primer sequences are included in S4 Table. Individual strains are listed in S5 Table. Plasmids
used for strain construction are included in S6 Table.
Erg5 and Stt4 were tagged using a PCR-based strategy [49]. The HA C-terminal tag and
selectable marker was amplified from pLC575 (HIS3) using oLC4028+oLC4029. The NAT-
pACT1-Flag N-terminal tag was amplified from pLC620 using oLC3401+oLC3402. The con-
structs were transformed into C. albicans strains using standard protocols. Proper integration
was confirmed by PCR using primer pairs oLC1645+oLC2944 and oLC3464+oLC241 for
Erg5-HA, and oLC3403+oLC275 and oLC3404+oLC274 for FLAG-Stt4. Expression was con-
firmed by Western blots.
The HSP90 double mutant strains were created by deleting one allele of HSP90 in the erg5Δ/
Δ and stt4Δ/Δ strains by transforming in pLC62 digested with KpnI and SacII and confirming
integration by PCR using primers oLC275+oLC276 and oLC274+oLC277. The SAP2 promoter
was then induced to drive expression of FLP recombinase to excise the NAT marker cassette.
The strains were then transformed with the tetO-HSP90 promoter replacement construct
amplified from pLC605 containing the NAT resistance marker using primers oLC3220 and
oLC3390. The NAT maker was then excised and lack of a wild-typeHSP90 was confirmed by
PCR using primers oLC294+oLC297.
The ypp1Δ/Δ, efr3Δ/Δ, and pikalphaΔ/Δ strains were created by sequential deletion and exci-
sion of the NAT resistance marker using standard PCR-based homologous recombination
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methods to generate precise gene deletions. The NAT cassette was amplified from pLC49 using
primers oLC4020 and oLC4021 for Ypp1, oLC4024 and oLC4025 for Efr3, and oLC4629 and
oLC4630 for Pikalpha. Proper integration was tested using oLC4022+oLC275 and oLC4023+
oLC274 for Ypp1, oLC274+oLC4026 and oLC275+oLC4027 for Efr3, and oLC275+oLC4632
and oLC274+oLC4633 for Pikalpha. Absence of a wild-type allele was confirmed using
oLC4022+oLC4023 for Ypp1, oLC4052+oLC4053 for Efr3, and oLC4685+oLC4632 for
Pikalpha.
Calculating genetic interactions
The growth of each mutant in each of the stress conditions was compared to its growth under
standard conditions to determine the relative fitness in each condition. The expected fitness of
the stress+geldanamycin condition was calculated using the Product Multiplicative Model (fit-
ness in stress  fitness in geldanamycin). Chemical genetic interactions were defined if the
observed fitness was less than half of the expected fitness in at least two independent mutants.
For the mutants with strong hypersensitivity to geldanamycin, chemical genetic interactions
were defined if the observed fitness was less than 90% of the expected fitness in at least two
independent mutants.
Western blotting and protein quantification
For Hsp90 levels and Flag-Stt4 levels, strains were inoculated overnight in YPD, subcultured to
an OD600 = 0.1 in fresh YPD, incubated for 4 hours at 30°C with shaking, and then 1 mL of
OD600 = 0.6 cells was collected. Pellets were washed once in 1X PBS before being resuspended
in 50 μL of 2X laemmli sample buffer. The sample was then boiled for 5 min, spun at 13,000
rpm for 5 minutes, and the lysate was then loaded on a 6% SDS gel. The sample was transferred
to a nitrocellulose membrane and blocked in 5% milk in PBS-T. Hsp90 levels were detected
using a native antibody against C. albicansHsp90 (Gift from B. Larsen). Flag-Stt4 levels were
detected using a mouse Monoclonal Anti-FLAGM2-Peroxidase (HRP) antibody (Sigma-
Aldrich).
For pHog1 levels, strains were inoculated overnight in YPD, subcultured to an OD600 = 0.1
in RPMI, and incubated to mid log phase at 30°C with shaking. To induce pHog1, cells were
incubated with 10 mM hydrogen peroxide for 10 minutes. Proteins were collected as described
above, and separated on a 12% SDS gel. The samples were then transferred to a nitrocellulose
membrane and blocked in 5% BSA in TBS-T. pHog1 levels were detected using the anti-phos-
pho-p38 MAPK T180/Y182 antibody (Cell Signalling). Hog1 levels were detected using the
Hog1 y-215 antibody (SC-9079 Santa Cruz).
Protein levels were normalized using an antibody against Tubulin (AbD Serotec rat anti-
tubulin MCA78G) or Histone H3 (Abcam 1791). Protein level quantifications were performed
using ImageJ, normalizing against the loading control, and relative levels were determined by
comparison with the wild-type strain under the same conditions.
MIC assays and checkerboards
Drug tolerance assays were performed in flat-bottom, 96-well microtiter plates (Sarstedt) using
a modified broth microdilution protocol as previously described [10]. For target gene depletion
in the tetO strains, cells were incubated overnight in 0.05μg/mL DOX before being assayed for
drug sensitivity in the presence of 0.05μg/mL DOX. MIC tests were set up in a total volume of
0.2 ml/well with 2-fold dilutions of each drug in either RPMI or YPD, as indicated. Plates were
incubated in the dark at either 30°C or 37°C, as indicated, before OD600 were determined using
a spectrophotometer (Molecular Devices). Each strain was tested in technical and biological
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replicates. MIC data were quantitatively displayed with color using the program Java TreeView
1.1.1 (http://jtreeview.sourceforge.net). Error bars represent standard deviation of biological
replicates. Dose response matrices were performed as previously described [50]. Fractional
inhibitory concentrations were determined as previously described [51], using the formula
FIC = (MICcombo / MICDrugA) + (MICcombo / MICDrugB).
Actin localization
Rhodamine-phalloidin staining of actin was performed on fixed cells as previously described
[15]. Briefly, cells were fixed in 4% formaldehyde after subculturing for 6 hours in RPMI at
37°C. For the GRACE strains, mutants were incubated in the presence or absence of 0.5 μg/mL
DOX overnight before subculturing in the presence or absence of 0.5 μg/mL DOX. After fixa-
tion, cells were washed twice in PBS, incubated overnight in rhodamine-phalloidin at 4°C,
washed twice in PBS, and imaged.
Microscopy
Microscopic imaging of C. albicans was performed on a Zeiss Axio Imager.MI (Carl Zeiss).
Fluorescence microscopy of rhodamine-phalloidin was performed using an X-Cite series 120
light source with an ET HQ tetramethylrhodamine isothiocyanate (TRITC)/DsRED filter set
from Chroma Technology (Bellows Falls, VT).
Macrophage virulence assay
ASC-mCherry macrophages (gift from Eicke Latz) were infected at an MOI of 1:1, as previ-
ously described [23]. Four hours post inoculation, infected macrophages were imaged using a
Zeiss Axio Observer.Z1 at × 10 magnification. Pyroptosis events were determined by foci of
red fluorescence, using ImageJ for quantification. Each experiment was performed in triplicate,
with three biological replicates. Statistical significance (P<0.05) was determined by unpaired t-
tests.
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S1 Table. Hsp90 chemical genetic interactors.
(XLSX)
S2 Table. Candida albicans PI biosynthesis and PH domain proteins.N/A indicates that the
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S1 Fig. STT4 and ERG5mutants are sensitive to geldanamycin, both as homozygous dele-
tion mutants and tetracycline-repressible gene expression strains.MIC assays were per-
formed in RPM1 with two fold dilutions of geldanamycin. + DOX lanes indicate that 20 μg/mL
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doxycycline was added to repress transcription from the tetO promoter. “A” indicates the wild
type from the GRACE collection that includes the tetracycline-repressible strains, and “B” indi-
cates the wild-type strain from the Noble collection that includes the homozygous deletion
mutants. The optical densities were read after incubation at 37°C for 72 hours. Technical repli-
cates were averaged; a representative image of one of two biological replicates is shown.
(PDF)
S2 Fig. Hsp90 genetic interactors influence antifungal drug tolerance and morphogenesis.
(A) Deletion mutants for genes identified as Hsp90 chemical genetic interactors and the wild
type (WT) were tested for susceptibility to caspofungin or fluconazole at 125 ng/mL of either
antifungal. Assays were performed in RPMI medium at 37°C for 48 hours and optical densities
at 600 nm were averaged for two biological replicates with two technical replicates each. Per-
cent growth is normalized to the no drug condition.  indicates p<0.05 compared to the wild
type strain using t-tests. (B) Identification of mutants blocked in filamentation in response to
Hsp90 inhibition. Cells were incubated in rich medium (YPD) with 10 μM geldanamycin at
30°C under shaking conditions for 6 hours before imaging. Scale bar is 10 microns.
(PDF)
S3 Fig. The tetO-STT4/stt4Δ strain was incubated overnight in the presence or absence of
0.5 μg/mL DOX before sub-culturing in RPMI ± DOX at 37°C for 6 hours before fixation
and staining with rhodamine-phalloidin for F-actin.
(PDF)
S4 Fig. ASC-mCherry macrophages were infected with the tetO-STT4/stt4Δ, tetO-ERG5/
erg5Δ, and GRACE parental strain in the presence or absence of 0.5 μg/mL DOX for four
hours and monitored for pyroptosis by foci of fluorescence.  indicates p< 0.05, error bars
indicate standard deviation. At least 500 infected cells were counted per strain.
(PDF)
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